Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine
Figure 2
Viability of HL-60 and THP-1 cells ± drug treatment. Percentage of dead HL-60 (top) and THP-1 (bottom) cells plated at (a) 0.05 × 106 cells/mL and (b) 0.5 × 106 cells/mL. Cells were treated with ara-C, CNDAC, and mitoxantrone in triplicate; data shown is from drug treatments for 3 and 4 days.
